Cardiotoxicity during long-term trastuzumab use in patients with HER2-positive metastatic breast cancer: who needs cardiac monitoring?
Bouwer NI, Steenbruggen TG, van Rosmalen J, Rier HN, Kitzen JJEM, van Bekkum ML, Tije AJT, de Jong PC, Drooger JC, Holterhues C, Smorenburg CH, Kofflard MJM, Boersma E, Sonke GS, Levin MD, Jager A.
Bouwer NI, et al. Among authors: levin md.
Breast Cancer Res Treat. 2021 Apr;186(3):851-862. doi: 10.1007/s10549-020-06039-w. Epub 2021 Jan 4.
Breast Cancer Res Treat. 2021.
PMID: 33394273
Free PMC article.